Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Copenhagen Stock Exchange  >  Novo Nordisk A/S    NOVO.B   DK0060534915

End-of-day quote. End-of-day quote  - 06/30
358.1 DKK   +0.84%
06/29 NOVO NORDISK A/ : Scores One for Partnerships
06/29 Novo Nordisk eyes technology tie-ups
06/29 Novo Nordisk eyes technology tie-ups
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Copenhagen Stock Exchange
06/24/2016 06/27/2016 06/28/2016 06/29/2016 06/30/2016 Date
345.1 341.9 347.5 355.1 358.1 Last
4485752 3398635 3313919 3291035 2903773 Volume
-0.89% -0.93% +1.64% +2.19% +0.84% Change
Financials ( DKK)
Sales 2016 114 708 M
EBIT 2016 49 589 M
Net income 2016 38 838 M
Finance 2016 10 548 M
Yield 2016 2,03%
Sales 2017 123 347 M
EBIT 2017 53 701 M
Net income 2017 42 540 M
Finance 2017 13 998 M
Yield 2017 2,25%
P/E ratio 2016 23,05
P/E ratio 2017 20,74
EV / Sales2016 6,14x
EV / Sales2017 5,68x
Capitalization 714 661 M
More Financials
Company
Novo Nordisk AS engages in the research, development, manufacture, and marketing of pharmaceutical products.It operates through the Diabetes and Obesity Care; and Biopharmaceuticals segments.The Diabetes and Obesity Care segment covers insulins, glucagon-like-peptide 1, other protein-related... 
Sector
Pharmaceuticals
Calendar
08/05Earnings Release
More about the company
Surperformance© ratings of Novo Nordisk A/S
Trading Rating : Investor Rating :
More Ratings
Latest news on NOVO NORDISK A/S
06/29 NOVO NORDISK A/S : Scores One for Partnerships
06/29 Novo Nordisk eyes technology tie-ups
06/29 Novo Nordisk eyes technology tie-ups
06/28 NOVO NORDISK A/S : EMA grants marketing authorisation of mylife(TM) YpsoPump® fo..
06/27 NOVO NORDISK A/S : - Share repurchase programme
06/26 NOVO NORDISK A/S : Danish healthcare organization seeks to expand collaboration ..
06/25 NOVO NORDISK A/S : Danish health team seeks cooperation beyond merely treating d..
06/23 NOVO NORDISK A/S : Patent Issued for Regeneration of Chromatographic Stationary ..
06/20 NOVO NORDISK A/S : - Share repurchase programme
06/16 NOVO NORDISK A/S : Findings from Novo Nordisk Broaden Understanding of Type 2 Di..
More news
Sector news : Pharmaceuticals - NEC
08:10a DAIICHI SANKYO : FTSE Russell Corporation Selects Daiichi Sankyo for FTSE4Good G..
08:01a OPKO HEALTH : to Acquire Transition Therapeutics
03:32aDJSHANGHAI FOSUN PHARMACEUTICAL () : Approves Listing of 66.2%-Owned Sisram Medica..
02:55a TAKEDA PHARMACEUTICAL : Announces New Assignment of Directors
06/29 NOVARTIS : PKC412 (midostaurin) pivotal data published in NEJM show 60% response..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
06/21 Vivus - Qsymia Sales Still Trending In The Wrong Direction
06/21 Novo Nordisk - Saxenda Continues To Buck Trends In Anti-Obesity
06/15 NOVO NORDISK : Victoza's Cardiovascular Victory
06/15 Novo Slumps As Leader Looks More Like A Follower
06/15 The Most Interesting Thing(s) I Saw In Today's Market
Advertisement
Chart NOVO NORDISK A/S
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO.B | DK0060534915 | 4-Traders
Full-screen chart
Technical analysis trends NOVO NORDISK A/S
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions